Goldman Sachs’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-70,000
Closed -$8.73M 7021
2013
Q3
$8.73M Buy
70,000
+59,000
+536% +$7.47M ﹤0.01% 2383
2013
Q2
$955K Buy
+11,000
New +$1.01M ﹤0.01% 4440

Goldman Sachs's ONXX Position: Q4 2013 in Review

Goldman Sachs sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 118,353 shares — an estimated $14.8M sold.

Goldman Sachs first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $14.8M in Q3 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • Goldman Sachs reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Goldman Sachs sold 118,353 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $14.8M.
  • Goldman Sachs first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Goldman Sachs's ONYX PHARMACEUTICALS INC position peaked at $14.8M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on Goldman Sachs's 13F filing for Q4 2013, filed 14 Feb 2014.